Literature DB >> 16613343

Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.

Yatsuki Aratake1, Hajime Nomura, Tomio Kotani, Kosuke Marutsuka, Kaoru Kobayashi, Kanji Kuma, Akira Miyauchi, Akihiko Okayama, Kazuo Tamura.   

Abstract

The aim of the present study was to clarify the underlying molecules that might contribute to the highly aggressive behavior of anaplastic thyroid carcinoma. We selected 5 cases of anaplastic thyroid carcinoma that had a differentiated area to determine differences in the molecules of undifferentiated and differentiated cancer cells. We immunohistochemically examined the localization of nuclear antigen (Ki-67), proliferating cell nuclear antigen (PCNA), p53, apoptotic protease-activating factor-1 (Apaf-1), CD26, galectin-3, E-cadherin, and CD147. We found increased Ki-67, PCNA, and p53 labeling indices; decreased levels of Apaf-1, CD26, galectin-3, and E-cadherin; and overexpression of CD147 in the undifferentiated area compared with the differentiated area. These findings indicate high proliferative properties, suppression of apoptosis, disruption of cell-cell interaction, and induction of matrix metalloproteinases in the undifferentiated areas. Thus the molecules examined might be useful for evaluating the aggressive nature of this tumor and the prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613343

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 2.  Diagnostic utility of galectin-3 in thyroid cancer.

Authors:  Connie G Chiu; Scott S Strugnell; Obi L Griffith; Steven J M Jones; Allen M Gown; Blair Walker; Ivan R Nabi; Sam M Wiseman
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

3.  Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Authors:  Darya Buehler; Heather Hardin; Weihua Shan; Celina Montemayor-Garcia; Patrick S Rush; Sofia Asioli; Herbert Chen; Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

4.  Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-10-01

5.  Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.

Authors:  Juliette Hommell-Fontaine; Angela Borda; Florence Ragage; Nicole Berger; Myriam Decaussin-Petrucci
Journal:  Virchows Arch       Date:  2010-04-23       Impact factor: 4.064

6.  Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma.

Authors:  Hüseyin K Türköz; Hülya Oksüz; Ziya Yurdakul; Deniz Ozcan
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.

Authors:  Krzysztof Fujarewicz; Michal Jarzab; Markus Eszlinger; Knut Krohn; Ralf Paschke; Małgorzata Oczko-Wojciechowska; Małgorzata Wiench; Aleksandra Kukulska; Barbara Jarzab; Andrzej Swierniak
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

Review 8.  Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review).

Authors:  Yong-Ju Gao; Bo Li; Xin-Yu Wu; Jing Cui; Jian-Kui Han
Journal:  Oncol Rep       Date:  2014-01-14       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.